首页 | 本学科首页   官方微博 | 高级检索  
   检索      

心尖肥厚型心肌病的临床特征及治疗
引用本文:史亚娜,王凡非,邓捷,王效增,韩雅玲.心尖肥厚型心肌病的临床特征及治疗[J].现代生物医学进展,2012,12(34):6684-6685,6646.
作者姓名:史亚娜  王凡非  邓捷  王效增  韩雅玲
作者单位:沈阳军区总医院心内科全军心血管病研究所 辽宁沈阳110016
摘    要:目的:总结心尖肥厚型心肌病的临床特征及治疗方法.方法:回顾性分析我院2008年6月至2012年2月期间经心脏超声或左室造影证实的33例心尖肥厚型心肌病患者的临床特征及治疗情况.结果:患者的临床症状表现为以胸闷、气短为主者20例;心前区不适4例;心前区疼痛5例;乏力2例;心悸l例;发现心电图异常前来就诊l例.32例患者行左室造影诊断为心尖肥厚型心肌病.l例因肾功能不全,未行左室造影,但经心脏超声诊断为心尖肥厚型心肌病.27例患者服用β-受体阻滞剂,2例患者服用钙离子拮抗剂,4例患者因心率慢,未服用药物,临床随访1~36(平均16.7± 4.1)个月,临床症状均明显缓解.结论:β-受体阻滞剂和钙离子拮抗剂均适用于治疗心尖肥厚型心肌病.

关 键 词:心尖肥厚型心肌病  临床特征  治疗

Clinical Characteristics and Therapies of Apical Hypertrophic Cardiomyopathy
SHI Ya-na,WANG Fan-fei,DENG Jie,WANG Xiao-zeng,HAN Ya-ling.Clinical Characteristics and Therapies of Apical Hypertrophic Cardiomyopathy[J].Progress in Modern Biomedicine,2012,12(34):6684-6685,6646.
Authors:SHI Ya-na  WANG Fan-fei  DENG Jie  WANG Xiao-zeng  HAN Ya-ling
Institution:(Department of Cardiology,Shenyang General Hospital,Cardiovascular Research Institute of PLA,Shenyang,Liaoning 110016,China)
Abstract:Objective: To summarize the clinical characteristics and therapies of apical hypertrophic cardiomyopathy(AHCM).Methods: The clinical characteristics and therapies of thirty-three patients who were hospitalized between June 2008 and February 2012 and suffered from AHCM identified by echocardiographic or left ventriculography and coronary angiography respectively were analyzed retrospectively.Results: The clinical presentations included chest distress and dyspnoea in 20 cases,angina in 5 cases,cardiopalmus in 4 cases,fatigue in 2 cases,palpitation in 1 cases.1 case visited because of electrocardiographic abnormality.30 cases were identified by left ventriculography,and 1 wasn't received the left ventriculography because of chronic kidney disease.27 patients were treated with β-receptor blocker and 2 patients took calcium antagonist.4 patients didn't receive any drugs because of intolerance.The clinical follow-up periods were 1~36(16.7±4.1)months.The symptomatic was significantly relieved.Conclusion:β-receptor blocker and calcium antagonist were both optimal for therapy of AHCM.
Keywords:Apical hypertrophic cardiomyopathy  Clinical Characteristics  Therapy
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号